Trial intelligence / Profile preview

Profhilo plus subcision versus subcision alone for atrophic acne scars

IRCT20201210049671N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2021
Countries
1
01

Overview

Phase 3, single-blind trial of hyaluronic acid in atrophic acne scar (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Improvement grading of the lesions according to a dermatologist opinion, Improvement grading of lesions according to ultrasonic evaluation and 1 more. Started Mar 2021; status: completed.

02

Drugs

hyaluronic acid
03

Conditions

atrophic acne scar

Beyond the preview

Go deeper on IRCT20201210049671N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201210049671N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call